Willis Towers Watson Public Limited Company filings document regulatory disclosures for an Ireland-incorporated advisory, broking and solutions company with ordinary shares listed on Nasdaq. The record includes Form 8-K reports for quarterly and annual results, Regulation FD materials, non-GAAP reconciliations and amended earnings disclosures.
Proxy materials describe board matters, executive compensation and shareholder voting. Other material-event filings cover definitive agreements, financing arrangements including a delayed-draw term loan facility, registered security information and capital-structure disclosures tied to WTW's operating businesses and acquisition activity.
Willis Towers Watson PLC executive Lucy Clarke, President of Risk & Broking, purchased 1,896 Ordinary Shares in an open-market trade at $263.365 per share. Following this transaction, she directly owns 22,717.453 Ordinary Shares of the company.
Willis Towers Watson PLC executive Lucy Clarke, President of Risk & Broking, purchased 1,896 Ordinary Shares in an open-market trade at $263.365 per share. Following this transaction, she directly owns 22,717.453 Ordinary Shares of the company.
Willis Towers Watson PLC executive Lucy Clarke, President of Risk & Broking, purchased 1,896 Ordinary Shares in an open-market trade at $263.365 per share. Following this transaction, she directly owns 22,717.453 Ordinary Shares of the company.
Willis Towers Watson PLC Chief Executive Officer Carl Aaron Hess reported an open-market purchase of 2,000 Ordinary Shares on 2026-05-04 at $255.08 per share. Following this transaction, his direct ownership increased to approximately 117,425 Ordinary Shares.
Willis Towers Watson posted solid first‑quarter growth with active deal activity. Revenue for the three months ended March 31, 2026 rose to $2.41 billion from $2.22 billion a year earlier, driven by both Health, Wealth & Career and Risk & Broking.
Profitability improved. Net income attributable to WTW increased to $297 million from $235 million, and diluted earnings per share climbed to $3.10 from $2.33. The effective tax rate fell to 18.6% from 21.5%, helped by a discrete UK tax benefit.
Cash flow and balance sheet shifted due to acquisitions and refinancing. Operating cash flow was a modest outflow of $10 million, while total cash, cash equivalents and restricted cash fell to $5.41 billion after $840 million used in investing, including the $1.05 billion Newfront Insurance Holdings acquisition. Long‑term debt rose to $6.30 billion, including a $550 million draw on a new delayed draw term loan used to repay $550 million of 4.400% senior notes due 2026.
Willis Towers Watson reported solid first-quarter 2026 growth with stronger profitability. Revenue rose 8% to $2.41 billion, with 3% organic growth, while net income increased 27% to $303 million. Diluted EPS grew 33% to $3.10 and adjusted diluted EPS rose 19% to $3.72, reflecting operating discipline.
Operating margin was 18.6%, down 80 bps, but adjusted operating margin improved 70 bps to 22.3% as cost controls and efficiency gains offset higher transaction and integration expenses. Health, Wealth & Career and Risk & Broking each delivered 9% reported revenue growth and 60 bps margin expansion.
Free cash flow remained negative at $(65) million, though it improved by $21 million year over year. The company repurchased $300 million of shares and paid $88 million in dividends, and it targets continued annual margin expansion, higher free cash flow margins and at least $1.0 billion of 2026 share repurchases, alongside the Newfront acquisition and the Willis Re joint venture effects on earnings.
Willis Towers Watson PLC reports that Vanguard Capital Management beneficially owns 7,106,088 shares of Common Stock. The filing states this represents 7.54% of the class, with 941,235 shares of sole voting power and 7,106,088 shares of sole dispositive power. The filing is signed by Vanguard's Head of Global Fund Administration.
Willis Towers Watson PLC PAO and Controller Joseph Stephen Kurpis reported routine equity compensation activity. On April 20, 2026, he received a grant of 96.944 time-based restricted share units (RSUs), each representing one ordinary share, at a price of $0.0000 per share. These RSUs vest in three equal installments on the first, second and third anniversaries of the grant date.
On April 21, 2026, 9.582 ordinary shares were disposed of at $297.64 per share through share withholding to cover taxes related to RSU vesting, rather than an open-market sale. After these transactions, Kurpis directly holds 1,692.416 ordinary shares, including one share from previously accrued dividend equivalent rights.
Willis Towers Watson Chief Human Resources Officer Kristy D. Banas reported routine equity compensation activity. On April 20, 2026, she received 770.817 time-based RSUs, representing the right to receive ordinary shares at no purchase price, vesting in three equal installments on the first, second, and third anniversaries of the grant date.
On April 21, 2026, 105.085 shares were disposed of at $297.64 per share through share withholding to cover taxes tied to RSU vesting, rather than an open-market sale. Following these transactions, she directly owns 11,298.9782 ordinary shares, which include 8 shares from previously accrued dividend equivalent rights.
Willis Towers Watson Chief Operating Officer Alexis Faber reported routine equity compensation activity. She received 848.268 time-based restricted share units (RSUs), representing the right to receive ordinary shares, which will vest in three equal installments on the first, second and third anniversaries of the grant date.
In connection with the vesting and settlement of earlier RSUs, 104.014 shares were withheld by the company to cover related tax obligations at an indicated price of $297.64 per share. After these transactions, Faber holds 11,475.847 ordinary shares directly and 1 share indirectly through an immediate family member, plus 9 additional shares from previously accrued dividend equivalent rights.
Willis Towers Watson executive Imran Ahmed Qureshi reported routine equity compensation activity. He received 1,053.749 time-based restricted share units (RSUs), each representing the right to receive an ordinary share. These RSUs vest in three equal annual installments on the first, second, and third anniversaries of the grant date.
The filing also shows 117.607 shares withheld by the company to cover taxes related to the vesting and settlement of earlier RSU awards, a non-market disposition. Following these transactions, Qureshi holds 2,352.656 shares directly and 9,860.871 shares indirectly through a revocable trust, reflecting a transfer of shares into that trust.
Willis Towers Watson PLC Co-Head of Corporate Development Anne Pullum reported routine equity compensation activity. On April 20, she received 1,053.749 time-based restricted share units (RSUs) that will vest in equal parts on the first, second, and third anniversaries of the grant date. On April 21, 144.263 ordinary shares were withheld by the company to cover taxes related to a prior RSU vesting, at a reference price of $297.64 per share. After these transactions, she directly holds 22,363.6803 ordinary shares, including 12 shares from previously accrued dividend equivalent rights.